Moving forward in the treatment of cholangiocarcinoma

Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatment of cholangiocarcinoma (CCA) are still unsatisfactory. In fact, survival after 5 years is expected in less than one fourth of patients diagnosed with this disease. Rare incidence, late appearance of sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzia, Tommaso M, Parente, Alessandro, Lenci, Ilaria, Sensi, Bruno, Milana, Martina, Gazia, Carlo, Signorello, Alessandro, Angelico, Roberta, Grassi, Giuseppe, Tisone, Giuseppe, Baiocchi, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713313/
https://www.ncbi.nlm.nih.gov/pubmed/35070034
http://dx.doi.org/10.4251/wjgo.v13.i12.1939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713313/
https://www.ncbi.nlm.nih.gov/pubmed/35070034
http://dx.doi.org/10.4251/wjgo.v13.i12.1939

Ejemplares similares